Driving value in phase IIIb & IV trials - Late Phase Drug Development World Americas 2013

Driving value in phase IIIb & IV trials
 

Late phase drug development world Americas 2013: Driving value in phase IIIb & IV trials   

  

  • Follow us on
  • follow us on twitter
  • join our LinkedIn network
  • subscribe to our RSS feed
  • email a friend
  • add dates to diary
  • Latest news

 Pharma/Biotech click here for free registration or call Rachel on +44 (0) 207 608 7045.

Show overview

Late Phase Drug Development World is an interactive conference with a flexible and diverse agenda including unique networking opportunities & panel discussions, giving you everything you need to know about late phase.

You will hear industry thought leaders from an impressive list of companies who will provide you with the best possible advice on how to
improve performance in late phase research.

More on exhibiting
More on attending

Why Late Phase Drug Development 2013?

Come to and learn how to:
 

  • Build cost-effective, non-interventional studies
  • Effectively collect, validate & analyze observational data
  • Gain market access globally based on late phase data
  • Turn insight from the real world into a commercial asset

Make an enquiry
Download more information

Focus on

  • Strategic challenges in late phase trials
  • Pipeline lifecycle management
  • Planning for phase IIIb/IV 
  • Analyzing and interpreting observational studies
  • Patient registries
  • Benefit/risk management
  • Real case studies in a range of therapeutic areas

More on exhibiting
More on attending

sponsors